Targeting of drug-loaded nanoparticles to tumor sites increases cell death and release of danger signals.

J Control Release

Department of Otorhinolaryngology, Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung Professorship, Universitätsklinikum Erlangen, Germany. Electronic address:

Published: September 2018

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2018.07.007DOI Listing

Publication Analysis

Top Keywords

targeting drug-loaded
4
drug-loaded nanoparticles
4
nanoparticles tumor
4
tumor sites
4
sites increases
4
increases cell
4
cell death
4
death release
4
release danger
4
danger signals
4

Similar Publications

Rheumatoid arthritis (RA) is an autoimmune disease that seriously threatens human health and affects the quality of life of patients. At present, pharmacotherapy is still the mainstream treatment for RA, but most methods have shortcomings, such as poor drug targeting, a low effective drug dosage at the inflammatory site, and high systemic toxicity. The combined application of drug-loaded nanobubbles and ultrasound technology provides a new technique for the treatment of RA.

View Article and Find Full Text PDF

Multi-Layered Microneedles Loaded with Microspheres.

AAPS PharmSciTech

January 2025

School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, 311 Ferst Drive, Atlanta, Georgia, 30332-0100, U.S.A..

Delivery of therapies into skin is attractive for medical indications including vaccination and treatment of dermatoses but is highly constrained by the stratum corneum barrier. Microneedle (MN) patches have emerged as a promising technology to enable non-invasive, intuitive, and low-cost skin delivery. When combined with biodegradable polymer formulations, MN patches can further enable controlled-release drug delivery without injection.

View Article and Find Full Text PDF

Quality-by-design principles applied to the development and optimisation of lidocaine-loaded dissolving microneedle arrays - a proof-of-concept.

Drug Deliv Transl Res

January 2025

Leicester Institute of Pharmaceutical, Health and Social Care Innovations, Leicester School of Pharmacy, De Montfort University, Leicester, LE1 9BH, UK.

The use of dissolving microneedle arrays (dMNA) for intradermal and transdermal drug delivery has been a growing trend in the field for the past decades. However, a lack of specific regulatory standards still hinders their clinical development and translation to market. It is also well-known that dMNA composition significantly impacts their performance, with each new formulation potentially presenting a challenge for developers, manufacturers and regulatory agencies.

View Article and Find Full Text PDF

Chemotherapy is essential for treating tumors, including head and neck cancer (HNC). However, the toxic side effects of chemotherapeutic drugs limit their widespread use. Therefore, a targeted delivery system that can transport the drug to the pathological site while minimizing damage to healthy tissues is urgently needed.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on using magnetic nanoparticles (MNP) combined with chitosan to improve targeted drug delivery for breast cancer treatment, aiming for better efficacy and fewer side effects.
  • MNPs were created through a co-precipitation method, and then encapsulated with the anti-cancer drug 5-fluorouracil (5-FU) in chitosan beads, followed by a variety of characterization techniques to confirm their properties.
  • Results indicated a high entrapment efficiency of 85-90% and notable cytotoxic effects on breast cancer cells, with drug release varying under different pH levels, suggesting a promising strategy for targeted cancer therapy.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!